Ketorolac Tromethamine, also known by its trade name Toradol®, is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for the treatment of moderate to severe pain, including pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders, and headaches. Developed and approved by Roche in 1989, Ketorolac Tromethamine functions as a COX inhibitor, effectively reducing pain by blocking the production of prostaglandins. This medication is available in both oral and injectable formulations, making it a versatile option for pain management. Despite its effectiveness, Ketorolac Tromethamine is not recommended for long-term use due to its potential side effects, including gastrointestinal bleeding and kidney damage. Click on the image below to begin the exploration journey of Ketorolac through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!